Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific Committee

Mesenchymal stromal cells (MSCs) are promising cell therapy candidates, but their debated efficacy in clinical trials still limits successful adoption. Here, we discuss proceedings from a roundtable session titled “Failure to Launch Mesenchymal Stromal Cells 10 Years Later: What's on the Horizo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cytotherapy (Oxford, England) England), 2024-05, Vol.26 (5), p.413-417
Hauptverfasser:	Robb, Kevin P., Galipeau, Jacques, Shi, Yufang, Schuster, Michael, Martin, Ivan, Viswanathan, Sowmya
Format:	Artikel
Sprache:	eng
Schlagworte:	Cell- and Tissue-Based Therapy - methods critical quality attribute graft-versus-host disease Humans inflammation Mesenchymal Stem Cell Transplantation - methods Mesenchymal Stem Cells - cytology mesenchymal stromal cell osteoarthritis patient stratification
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!